Comparative genomics on ROR1 and ROR2 orthologs

被引:3
|
作者
Katoh, M
Katoh, M
机构
[1] Natl Canc Ctr, Res Inst, Genet & Cell Biol Sect, Chuo Ku, Tokyo 1040045, Japan
[2] M&M Med BioInformat, Hongo 1130033, Japan
关键词
bioinformatics; comparative genomics; comparative proteomics; WNT; stem cell genomics; integrome network;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Transmembrane proteins with extracellular Frizzled domain, such as ROR1, ROR2, MUSK, MFRP, FZD1, FZD2, FZD3, FZD4, FZD5, FZD6, FZD7, FZD8, FZD9 and FZD10, are key molecules for WNT signaling network. Here, comparative integromics analyses on ROR1 and ROR2 orthologs were performed by using bioinformatics. Zebrafish ror2 gene, consisting of nine exons, was identified within CR450684.3 genome sequence. CV490605.1 EST corresponded to the 5'-end of zebrafish ror2 mRNA, and BM533602.1 EST corresponded to the 3'-end. Zebrafish ror2 gene was found to encode a 939-aa transmembrane protein, showing 71.7% and 56.2% total amino-acid identity with human ROR2 and ROR1, respectively. Immunoglobulin-like domain, Frizzled domain, Kringle domain within the extracellular region, tyrosine kinase domain, Ror homology C-terminal (RORHC) domain and juxta-C-terminal LLGD motif within the cytoplasmic region were conserved among vertebrate ROR1 and ROR2 orthologs. SH2 binding site within the RORHC domain was conserved among vertebrate ROR2 orthologs, but not among vertebrate ROR1 orthologs. ROR1 mRNA was expressed in embryonic stem (ES) cells, infant brain; renal cancer, and colon cancer. ROR2 mRNA was expressed in parathyroid, testis, uterus, and also in diffuse type gastric cancer with signet ring cell features. ROR2 promoter rather than ROR1 promoter was more evolutionarily conserved. WNT5A and ROR family receptors, co-expressed in ES cells and gastric cancer, are implicated in the planar cell polarity (PCP) pathway. ROR1 and ROR2 are the pharmacogenomics targets in the fields of stem cell biology and oncology.
引用
收藏
页码:1381 / 1384
页数:4
相关论文
共 50 条
  • [1] ROR1 and ROR2 expression in pancreatic cancer
    Dongli Liu
    George Sharbeen
    Phoebe Phillips
    Caroline E. Ford
    [J]. BMC Cancer, 21
  • [2] ROR1 and ROR2 expression in pancreatic cancer
    Liu, Dongli
    Sharbeen, George
    Phillips, Phoebe
    Ford, Caroline E.
    [J]. BMC CANCER, 2021, 21 (01)
  • [3] Identification and characterization of rat Ror1 and Ror2 genes in silico
    Katoh, M
    Katoh, M
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2005, 15 (03) : 533 - 538
  • [4] ROR1 and ROR2 in human malignancies: potentials for targeted therapy
    Rebagay, Guilly
    Yan, Su
    Liu, Cheng
    Cheung, Nai-Kong
    [J]. FRONTIERS IN ONCOLOGY, 2012, 2
  • [5] ROR1 and ROR2 play distinct and opposing roles in endometrial cancer
    Henry, C. E.
    Llamosas, E.
    Daniels, B.
    Coopes, A.
    Tang, K.
    Ford, C. E.
    [J]. GYNECOLOGIC ONCOLOGY, 2018, 148 (03) : 576 - 584
  • [6] Orphan receptor tyrosine kinases ROR1 and ROR2 in hematological malignancies
    Daneshmanesh, Amir Hossein
    Porwit, Anna
    Hojjat-Farsangi, Mohammad
    Jeddi-Tehrani, Mahmood
    Tamm, Katja Pokrovskaja
    Grander, Dan
    Lehmann, Soren
    Norin, Stefan
    Shokri, Fazel
    Rabbani, Hodjattallah
    Mellstedt, Hakan
    Osterborg, Anders
    [J]. LEUKEMIA & LYMPHOMA, 2013, 54 (04) : 843 - 850
  • [7] Genetic interactions between Ror2 and Wnt9a, Ror1 and Wnt9a and Ror2 and Ror1: Phenotypic analysis of the limb skeleton and palate in compound mutants
    Weissenboeck, Martina
    Latham, Richard
    Nishita, Michiru
    Wolff, Lena Ingeborg
    Ho, Hsin-Yi Henry
    Minami, Yasuhiro
    Hartmann, Christine
    [J]. GENES TO CELLS, 2019, 24 (04) : 307 - 317
  • [8] Migration and invasion is inhibited by silencing ROR1 and ROR2 in chemoresistant ovarian cancer
    Henry, C. E.
    Llamosas, E.
    Djordjevic, A.
    Hacker, N. F.
    Ford, C. E.
    [J]. ONCOGENESIS, 2016, 5 : e226 - e226
  • [9] Shock and ROR! Targeting ROR1 and ROR2 in a preclinical patient-derived model of ovarian cancer
    Henry, Claire E.
    Hacker, Neville F.
    Ford, Caroline E.
    [J]. CANCER RESEARCH, 2018, 78 (13)
  • [10] Migration and invasion is inhibited by silencing ROR1 and ROR2 in chemoresistant ovarian cancer
    C E Henry
    E Llamosas
    A Djordjevic
    N F Hacker
    C E Ford
    [J]. Oncogenesis, 2016, 5 : e226 - e226